A compound having the general structure shown in Formula I: ##STR00001## or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK.sub.1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

 
Web www.patentalert.com

< Modulation of STAT5 expression

< Antisense modulation of connective tissue growth factor expression

> Pyrrolo-pyridine kinase modulators

> Tetrahydroquinoline derivatives useful as serine protease inhibitors

~ 00603